A detailed history of Harris Associates L P transactions in Becton Dickinson & CO stock. As of the latest transaction made, Harris Associates L P holds 1,291,893 shares of BDX stock, worth $225 Million. This represents 0.52% of its overall portfolio holdings.

Number of Shares
1,291,893
Previous 893,355 44.61%
Holding current value
$225 Million
Previous $203 Billion 99.85%
% of portfolio
0.52%
Previous 0.27%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 15, 2025

BUY
$222.79 - $249.08 $88.8 Million - $99.3 Million
398,538 Added 44.61%
1,291,893 $296 Million
Q4 2024

Feb 14, 2025

BUY
$220.02 - $243.75 $197 Million - $218 Million
893,355 New
893,355 $203 Billion

Others Institutions Holding BDX

About BECTON DICKINSON & CO


  • Ticker BDX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 285,195,008
  • Market Cap $49.7B
  • Description
  • Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...
More about BDX
Track This Portfolio

Track Harris Associates L P Portfolio

Follow Harris Associates L P and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Harris Associates L P, based on Form 13F filings with the SEC.

News

Stay updated on Harris Associates L P with notifications on news.